Skip to main content
康乐卫士 logo

康乐卫士 — Investor Relations & Filings

Ticker · 920575 ISIN · CNE1000059W8 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 537 across all filing types
Latest filing 2026-04-28 Annual Report
Country CN China
Listing Beijing Stock Exchange 920575

About 康乐卫士

https://www.klws.com/

Beijing Health Guard Biotechnology Inc. is a clinical-stage biopharmaceutical company specializing in the research, development, and commercialization of innovative recombinant human vaccines. The company leverages advanced structural biology and protein engineering platforms to create a diverse pipeline of vaccine candidates. Its primary focus includes the development of high-valent human papillomavirus (HPV) vaccines, with its trivalent and nine-valent candidates in late-stage clinical trials. Additionally, the company is advancing candidates for respiratory syncytial virus (RSV), shingles, and other infectious diseases. By utilizing recombinant protein technology, Health Guard aims to provide high-quality, affordable immunization solutions to address significant unmet medical needs. Its technical expertise encompasses antigen design, high-throughput screening, and large-scale manufacturing processes.

Recent filings

Filing Released Lang Actions
2025年年度报告
Annual Report Classification · 100% confidence The document is titled '2025年年度报告' which translates to '2025 Annual Report' and contains detailed sections typical of an annual report such as company overview, financial data, management discussion and analysis, major events, shareholder information, financing and profit distribution, board and senior management information, industry information, corporate governance, and full financial accounting reports. It includes comprehensive financial data for the year 2025, quarterly breakdowns, risk disclosures, and detailed business and operational reviews. The document is lengthy (15,000 characters) and contains actual financial statements and substantive analysis, not just an announcement or summary. The presence of auditor information and detailed financial metrics further confirms this is a full annual report. Therefore, the document fits the definition of an Annual Report (10-K). FY 2025
2026-04-28 Chinese
内部控制审计报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Internal Control Audit Report" for Beijing Kangle Weishi Biotechnology Co., Ltd. It is issued by a licensed accounting firm and includes an audit opinion on the effectiveness of internal controls over financial reporting as of December 31, 2025. The document contains detailed auditor statements, certifications, and professional credentials of the auditors. It does not contain full financial statements or comprehensive annual financial performance data typical of an Annual Report (10-K) or Interim Report (IR). Instead, it focuses solely on the audit of internal controls related to financial reporting. This matches the definition of an Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles. The document length is under 5,000 characters, but it is a full audit report, not merely an announcement or certification. Therefore, the correct classification is AR with high confidence. FY 2025
2026-04-28 Chinese
股票停牌一个交易日公告
Delisting Announcement Classification · 95% confidence The document is a short announcement (1215 characters) regarding the suspension (停牌) of the company's stock trading for one trading day due to the company's audited net asset being negative, triggering a delisting risk warning under the Beijing Stock Exchange listing rules. It references a previous announcement about the delisting risk warning and states the suspension and resumption dates. The document also outlines the company's planned measures to improve financial conditions and maintain shareholder interests. There are no financial statements or detailed financial data presented, only a regulatory announcement about stock suspension and risk warning. This fits the definition of a Delisting Announcement (DLST) rather than a full financial report or other filing types.
2026-04-28 Chinese
2025年度独立董事述职报告（李晓静）
Board/Management Information Classification · 95% confidence The document is titled as the "2025年度独立董事述职报告（李晓静）" which translates to the "2025 Annual Independent Director's Work Report." It is a detailed report by an independent director about their duties, attendance, and activities during the year 2025. The content includes descriptions of board meetings attended, committee participation, communication with auditors, and other governance-related activities. It does not contain financial statements or financial performance data, nor is it an announcement or notice. It is a management or governance-related report focusing on the independent director's role and activities. This fits best under Board/Management Information (MANG) as it relates to board member duties and changes in management roles (including appointments and resignations). The document also discusses appointments of senior management and board members, which further supports classification as MANG. The document length is about 4936 characters, which is sufficient for a detailed report rather than a brief announcement. Therefore, the most appropriate classification is MANG with high confidence.
2026-04-28 Chinese
董事、高级管理人员薪酬管理制度
Remuneration Information Classification · 95% confidence The document is titled "董事、高级管理人员薪酬管理制度" which translates to "Remuneration Management System for Directors and Senior Management." It details the remuneration policies, principles, payment methods, and management structure for the company's directors and senior executives. It includes sections on salary standards, performance evaluation, payment methods, and clawback provisions. The document is a formal announcement of the remuneration system rather than a report of actual compensation figures or a proxy statement. It does not contain financial statements or earnings data, nor is it a meeting presentation or voting result. Given the detailed focus on executive compensation policies and management, this fits the definition of a Remuneration Information filing (DEF 14A). The document length is 2744 characters, which is consistent with a detailed policy announcement rather than a brief notice or a full annual report.
2026-04-28 Chinese
董事会关于独立董事独立性自查情况的专项报告
Governance Information Classification · 95% confidence The document is a special report from the board of directors regarding the independence self-assessment of the company's independent directors. It references regulatory guidelines related to independent directors and provides a detailed conclusion on their independence status. The content is focused on governance and compliance with independence requirements rather than financial results or other report types. It is not an announcement of a meeting, voting results, or a financial report. The document fits best under Governance Information (CGR) as it details the company's internal governance practices concerning independent directors.
2026-04-28 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.